Statistics

Total Visits

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice60

Select a period of time:

Number of views in the range

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice27

Views

Views
June 20250
July 202515
August 20250
September 20258
October 20250
November 20254
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Brazil6
Argentina1
Kenya1
Paraguay1
Turkey1
South Africa1
 

Top cities views

Views
Dallas7
Asunción1
Belo Horizonte1
Brasília1
Dolores1
Johannesburg1
Kilis1
Miami1
Nairobi1
New City1